drugset / Trial / NCT06671873
Study on Mass Balance of [14C]HMPL-306（Isocitrate Dehydrogenase Inhibitor） in Healthy Chinese Adult Male Subjects
NaSingle-groupOpen-labelHealth-services research
Summary
To evaluate the absorption, metabolism and excretion in healthy Chinese male subjects after a single oral dose of \[14C\]HMPL-306
Timeline
- Start
- 2024-11-26
- Primary completion
- 2025-02-28
- Completion
- 2025-07-02
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | RANOSIDENIB | Small molecule | 250 mg | Oral |
Indications
No indication recorded.